Table 1.
No. | Target full name | Target abbreviation | Protein ID/UniProtKB | State/conformation | Marka | Number of pocketsb | Orthosteric pocketsc | PDB ID | Sequence similarity (%) |
---|---|---|---|---|---|---|---|---|---|
1 | Host translation inhibitor nsp 1 | Nsp 1 | QHD43415.1 | /d | V1 | 3 | / | 2HSX | 86.09 |
2 | Non-structural protein 2 | Nsp 2 | QHD43415.1 | / | V2 | 13 | / | / | / |
3 | Papain-like proteinase | PLP/PLpro | QHD43415.1 | Monomer | V3-1 | 6 | 1 | 3E9S | 82.86 |
Dimer | V3-2 | 9 | 1 | 5Y3E | 82.80 | ||||
4 | ADP ribose phosphatase | ADRP | QHD43415.1 | Monomer | V4-1* | 1 | 1 | 6W02 | / |
Dimer | V4-2* | 5 | 2, 3 | 6W02 | / | ||||
5 | Non-structural protein 4 | Nsp 4 | QHD43415.1 | / | V5 | 7 | / | / | / |
6 | 3C-like proteinase | 3CLpro/Mpro | QHD43415.1 | Monomer | V6-1 | 4 | 2 | 1Z1I | 96.01 |
Monomer | V6-2* | 7 | 1 | 5R82 | / | ||||
Dimer | V6-3 | 6 | 3, 4 | 2Z9J | 96.08 | ||||
Dimer | V6-4* | 7 | 3, 4 | 6Y2G | / | ||||
MD1# | V6-5 | 6 | 1 | 1Z1I | 96.01 | ||||
MD2# | V6-6 | 6 | 2 | 1Z1I | 96.01 | ||||
MD3# | V6-7 | 6 | 3 | 1Z1I | 96.01 | ||||
MD4# | V6-8 | 7 | 3 | 1Z1I | 96.01 | ||||
7 | Non-structural protein 6 | Nsp 6 | QHD43415.1 | / | V7 | 7 | / | / | / |
8 | Non-structural protein 7 | Nsp 7 | QHD43415.1 | / | V8 | 1 | / | 1YSY | 98.80 |
9 | Non-structural protein 8 | Nsp 8 | QHD43415.1 | / | V9 | 1 | / | 2AHM | 97.42 |
10 | Non-structural protein 9 | Nsp 9 | QHD43415.1 | Monomer | V10-1 | 3 | / | 1UW7 | 97.35 |
Monomer | V10-2* | 3 | / | 6W4B | / | ||||
Dimer | V10-3 | 7 | / | 1QZ8 | 97.35 | ||||
Dimer | V10-4* | 6 | / | 6W4B | / | ||||
11 | Non-structural protein 10 | Nsp 10 | QHD43415.1 | / | V11 | 3 | / | 5NFY | 98.47 |
12 | RNA-dependent RNA polymerase | RdRp | QHD43415.1 | / | V12-1 | 10 | / | 6NUR | 96.35 |
+Mg2+ | V12-2 | 10 | / | 6NUR | 96.35 | ||||
13 | Helicase | / | QHD43415.1 | Monomer | V13-1 | 11 | / | 6JYT | 99.83 |
Dimer | V13-2 | 21 | / | 6JYT | 99.83 | ||||
14 | Guanine-N7 methyltransferase | N7 Mtase | QHD43415.1 | / | V14 | 12 | 1 | 5NFY | 94.88 |
15 | Uridylate-specific endoribonuclease | NendoU | QHD43415.1 | Monomer | V15-1 | 7 | / | 2H85 | 88.12 |
Monomer | V15-2* | 8 | / | 6W01 | / | ||||
Dimer | V15-3* | 15 | / | 6W01 | / | ||||
16 | 2ʹ-O-Methyltransferase | 2ʹ-O-Mtase | QHD43415.1 | / | V16 | 5 | 1 | 2XYR | 93.49 |
17 | ORF7a protein | / | QHD43421.1 | / | V17 | 1 | / | 1YO4 | 91.57 |
18 | Spike protein | S protein | QHD43416.1 | Closed | V18-1 | 25 | / | 5X58 | 76.48 |
Closed | V18-2* | 30 | / | 6VXX | / | ||||
Open | V18-3 | 27 | / | 5 × 5B | 76.48 | ||||
Open | V18-4* | 42 | / | 6VYB | / | ||||
Heptad repeat 1 | V18-5 | 12 | / | 5ZVM | 87.50 | ||||
S2 subunit | V18-6* | 4 | 6LXT | / | |||||
19 | Envelope protein | E protein | QHD43418.1 | Monomer | V19-1 | 1 | / | 2MM4 | 91.38 |
Pentamer | V19-2 | 2 | / | 5X29 | 91.38 | ||||
20 | Nucleocapsid phosphoprotein | N protein | QHD43423.2 | C terminal | V20-1 | 1 | / | 2GIB | 96.04 |
N terminal monomer | V20-2 | 4 | / | 2OFZ | 92.06 | ||||
N terminal monomer | V20-3* | 3 | / | 6VYO | / | ||||
N terminal-tetramer | V20-4* | 16 | / | 6VYO | / | ||||
21 | Angiotensin converting enzyme 2 | ACE2 | P59594 | / | H1* | 6 | / | 1R42 | / |
22 | Cathepsin L | CTSL | P07711 | / | H2* | 5 | 1 | 2XU3 | / |
23 | Transmembrane protease serine 2 | TMPRSS2 | O15393 | / | H3 | 10 | / | / | / |
24 | C type lectin domain family four member M | CLEC4M | Q9H2X3 | / | H4* | 2 | / | 1XAR | / |
25 | AP2-associated protein kinase 1 | AAK1 | Q2M2I8 | / | H5* | 12 | 1, 6 | 5TE0 | / |
26 | Cyclophilin A | CypA | P62937 | / | H6* | 3 | 1 | 4N1M | / |
27 | Disintegrin and metalloproteinase domain-containing protein 17 | ADAM17 | P78536 | / | H7-1 | 5 | 1 | 2I47 | 99.21 |
+Zn2+ | H7-2 | 5 | 1 | 2I47 | 99.21 | ||||
28 | Furin | / | P09958 | / | H8* | 8 | 1 | 5JXG | / |
29 | Tyrosine-protein kinase ABL2 | ABL2 | P42684 | / | H9* | 3 | 1 | 3HMI | / |
30 | Eukaryotic initiation factor 4A-I | eIF4A | P60842 | / | H10* | 8 | 2 | 5ZC9 | / |
31 | Dihydroorotate dehydrogenase | DHODH | Q02127 | / | H11* | 6 | 1 | 3U2O | / |
32 | Glycogen synthase kinase-3 beta | GSK3β | P49841 | / | H12* | 13 | 1 | 1J1B | / |
33 | Heterogeneous nuclear ribonucleoprotein A1 | HNRNPA1 | P09651 | / | H13* | 4 | / | 1U1Q | / |
34 | Calnexin | / | P27823 | / | H14-1 | 7 | / | 1JHN | 95.73 |
+Ca2+ | H14-2 | 7 | / | 1JHN | 95.73 | ||||
35 | Mitogen-activated protein kinase 8 | JNK1 | P45983 | / | H15 | 12 | 1 | 2G01 | 99.44 |
36 | Mitogen-activated protein kinase 9 | JNK2 | P45984 | / | H16 | 6 | 1 | 3NPC | 98.31 |
37 | Mitogen-activated protein kinase 10 | JNK3 | P53779 | / | H17* | 7 | 1 | 1JNK | / |
38 | RAC-alpha serine/threonine-protein kinase | AKT1 | P31749 | / | H18* | 8 | 1 | 3O96 | / |
39 | RAC-beta serine/threonine-protein kinase | AKT2 | P31751 | / | H19* | 12 | 1 | 3D0E | / |
40 | RAC-gamma serine/threonine-protein kinase | AKT3 | Q9Y243 | / | H20* | 5 | / | 2X18 | / |
41 | Caveolin-2 | CAV2 | P51636 | / | H21 | 2 | / | / | / |
42 | cGMP-specific 3ʹ,5ʹ-cyclic phosphodiesterase | PDE5 | O76074 | / | H22* | 10 | 1 | 2H44 | / |
*Crystal structures of SARS-CoV-2 or human proteins downloaded from PDB.
#Conformations clustered from molecular dynamics trajectories.
V refers to the SARS-CoV-2 protein, and H refers to the human protein.
The number of predicted binding pockets by D3Pockets on the protein with the PPV greater than 200 Å3.
The orthosteric ligand binding sites assigned based on its sequence similarity (>80%) to that of its homologous proteins.
Not available.